Sourced product has unverified purity, sterility, and dosing
GLP1 receptor agonists (e.g., semaglutide) and dual GLP1 receptor agonists/GIP agonists (e.g., tirzepatide) have been shown to significantly reduce weight in patients with obesity, with and without type 2 diabetes
Thats why we strive to make IV therapy both accessible and affordable for our patients
Conclusion: Weekly s.c
Clinical study protocols had participants take their last dose of semaglutide at least 3 days but no more than 10 days before starting tirzepatide
A placebo-controlled trial of the classic wellness drip, the Myers cocktail, found no statistically significant benefit over placebo in the studys primary outcome, a finding worth knowing before paying for any generic wellness infusion, and even in critically ill patients, a large randomized trial found that high-dose intravenous vitamin C did not significantly improve the outcomes it was expected to, which cautions against extrapolating dramatic benefits to healthy wellness drips